Status:
COMPLETED
Pharmacist Management of Paxlovid eVisits
Lead Sponsor:
Kaiser Permanente
Conditions:
COVID-19
Quality of Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visit...
Detailed Description
Importance. Enhancing the management of messages from patients and providing virtual options for urgent care are top priorities for The Permanente Medical Group (TPMG) and Kaiser Foundation Hospitals/...
Eligibility Criteria
Inclusion
- Patients making Paxlovid e-visits on weekdays from 8:00 am to 4:30 pm during the study period
Exclusion
- None
Key Trial Info
Start Date :
October 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 11 2024
Estimated Enrollment :
2478 Patients enrolled
Trial Details
Trial ID
NCT06076863
Start Date
October 9 2023
End Date
January 11 2024
Last Update
March 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Northern California
Oakland, California, United States, 94612